chr1-158611097-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003126.4(SPTA1):​c.*167A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.257 in 913,686 control chromosomes in the GnomAD database, including 31,521 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5056 hom., cov: 29)
Exomes 𝑓: 0.26 ( 26465 hom. )

Consequence

SPTA1
NM_003126.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.874
Variant links:
Genes affected
OR10Z1 (HGNC:14996): (olfactory receptor family 10 subfamily Z member 1) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
SPTA1 (HGNC:11272): (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 1-158611097-T-C is Benign according to our data. Variant chr1-158611097-T-C is described in ClinVar as [Benign]. Clinvar id is 292923.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-158611097-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.284 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
OR10Z1NM_001004478.2 linkuse as main transcriptc.*3717T>C 3_prime_UTR_variant 2/2 ENST00000641002.1
SPTA1NM_003126.4 linkuse as main transcriptc.*167A>G 3_prime_UTR_variant 52/52 ENST00000643759.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
OR10Z1ENST00000641002.1 linkuse as main transcriptc.*3717T>C 3_prime_UTR_variant 2/2 NM_001004478.2 P1
SPTA1ENST00000643759.2 linkuse as main transcriptc.*167A>G 3_prime_UTR_variant 52/52 NM_003126.4 P1P02549-1

Frequencies

GnomAD3 genomes
AF:
0.254
AC:
38208
AN:
150226
Hom.:
5052
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.203
Gnomad AMI
AF:
0.228
Gnomad AMR
AF:
0.221
Gnomad ASJ
AF:
0.316
Gnomad EAS
AF:
0.181
Gnomad SAS
AF:
0.244
Gnomad FIN
AF:
0.304
Gnomad MID
AF:
0.326
Gnomad NFE
AF:
0.288
Gnomad OTH
AF:
0.260
GnomAD4 exome
AF:
0.257
AC:
196253
AN:
763342
Hom.:
26465
Cov.:
10
AF XY:
0.257
AC XY:
100466
AN XY:
390480
show subpopulations
Gnomad4 AFR exome
AF:
0.198
Gnomad4 AMR exome
AF:
0.176
Gnomad4 ASJ exome
AF:
0.310
Gnomad4 EAS exome
AF:
0.179
Gnomad4 SAS exome
AF:
0.240
Gnomad4 FIN exome
AF:
0.270
Gnomad4 NFE exome
AF:
0.268
Gnomad4 OTH exome
AF:
0.250
GnomAD4 genome
AF:
0.254
AC:
38241
AN:
150344
Hom.:
5056
Cov.:
29
AF XY:
0.256
AC XY:
18762
AN XY:
73294
show subpopulations
Gnomad4 AFR
AF:
0.203
Gnomad4 AMR
AF:
0.221
Gnomad4 ASJ
AF:
0.316
Gnomad4 EAS
AF:
0.182
Gnomad4 SAS
AF:
0.245
Gnomad4 FIN
AF:
0.304
Gnomad4 NFE
AF:
0.288
Gnomad4 OTH
AF:
0.263
Alfa
AF:
0.269
Hom.:
1475
Bravo
AF:
0.244
Asia WGS
AF:
0.214
AC:
747
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxNov 12, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Elliptocytosis 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Hereditary spherocytosis type 3 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Pyropoikilocytosis, hereditary Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
7.7
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3768535; hg19: chr1-158580887; COSMIC: COSV100779116; COSMIC: COSV100779116; API